RPUSD1: A Potential Drug Target and Biomarker for DNA Replication

Target Name: RPUSD1

NCBI ID: G113000

RPUSD1

Other Name(s): RNA pseudouridine synthase domain containing 1, transcript variant 1 | C16orf40 | Ribosomal large subunit pseudouridine synthase C-like protein | RNA pseudouridylate synthase domain-containing protein 1 (isoform 1) | Ribosomal large subunit pseudouridine synthase C like | RNA pseudouridine synthase domain containing 1 | RUSD1_HUMAN | ribosomal large subunit pseudouridine synthase C-like protein | RLUCL | RPUSD1 variant 1 | RNA pseudouridylate synthase domain containing 1 | RNA pseudouridylate synthase domain-containing protein 1

RPUSD1: A Potential Drug Target and Biomarker for DNA Replication

RNA pseudouridine synthase domain containing 1 (RPUSD1) is a protein that plays a crucial role in the regulation of DNA replication in eukaryotic cells. It is a key enzyme in the DNA replication machinery, which is responsible for copying the genetic information from the DNA template to the newly synthesized RNA molecule.RPUSD1 is a protein that is expressed in all eukaryotic cells and is highly conserved across different species.

RPUSD1 is a member of the RNA-protein subfamily, which is characterized by the presence of a protein that contains a domain that is responsible for protein-protein interactions and is often involved in the regulation of cellular processes.RPUSD1 contains a pseudouridine synthase domain, which is responsible for catalyzing the synthesis of pseudouridine nucleotides from the precursor nucleotides.

RPUSD1 is involved in the regulation of DNA replication, which is a critical process for the growth and development of eukaryotic cells. During DNA replication, RPUSD1 is involved in the formation of the double helix, which is the template for the synthesis of the new RNA molecule.RPUSD1 is also involved in the regulation of the initiation of DNA replication, as well as the regulation of the elongation of the double helix during DNA replication.

RPUSD1 is a potential drug target for diseases that are caused by disruptions in the regulation of DNA replication. For example, RPUSD1 is often overexpressed in cancer cells, which allows them to continue to grow and multiply uncontrollably.RPUSD1 has also been shown to be involved in the regulation of gene expression, which may be a potential target for drugs that are designed to inhibit its activity.

RPUSD1 is also a potential biomarker for diseases that are caused by disruptions in the regulation of DNA replication. For example, RPUSD1 has been shown to be involved in the regulation of the outcome of many therapeutic treatments, including cancer chemotherapy.RPUSD1 levels have been shown to be elevated in the blood of patients who have undergone chemotherapy, which may be a potential indicator of the effectiveness of the treatment.

RPUSD1 is a protein that plays a crucial role in the regulation of DNA replication in eukaryotic cells. It is a potential drug target for diseases that are caused by disruptions in the regulation of DNA replication, as well as a potential biomarker for diseases that are treated with chemotherapy. Further research is needed to fully understand the role of RPUSD1 in the regulation of DNA replication and its potential as a drug target or biomarker.

Protein Name: RNA Pseudouridine Synthase Domain Containing 1

The "RPUSD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPUSD1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets